Showing results (431-440 of 440) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 440 results.
BMC Infectious Diseases|August 5, 2016
The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosisAlison S Devonshire, Denise M O'Sullivan, Isobella Honeyborne, et al.
The Journal of Antimicrobial Chemotherapy|July 4, 2025
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TBSimon E Koele, Krista Stoycheva, Cyprian Mtweve, et al.
The Lancet. Infectious Diseases|July 11, 2025
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trialNorbert Heinrich, Christina Manyama, Simon E Koele, et al.
The Lancet. Infectious Diseases|July 11, 2025
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trialLilian Tina Minja, Isabella van der Feltz, Christina Manyama, et al.
Annals of Clinical Microbiology and Antimicrobials|May 9, 2025
Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of CongoBreli Bonheur Ngouama, Jean Claude Djontu, Darrel Ornelle Elion Assiana, et al.
Critical Care (London, England)|December 23, 2025
Systematic review and meta-analysis of humoral immunity proteins and mortality in sepsisAntoine Villa, Fiona Dewar, Walter Pisciotta, et al.
Nature Microbiology|April 15, 2024
Age-specific nasal epithelial responses to SARS-CoV-2 infectionMaximillian N J Woodall, Ana-Maria Cujba, Kaylee B Worlock, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 25, 2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBC D Tweed, G H Wills, A M Crook, et al.
Global Change Biology|March 22, 2022
Bridge to the future: Important lessons from 20 years of ecosystem observations made by the OzFlux networkJason Beringer, Caitlin E Moore, Jamie Cleverly, et al.
Nature Reviews. Drug Discovery|July 18, 2015
Towards host-directed therapies for tuberculosisAlimuddin Zumla, Markus Maeurer, , et al.
Pageof 44